Update on pharmacology of antiplatelets, anticoagulants, and thrombolytics

被引：12

作者：

Cheng-Ching, Esteban ^{[1
]}

Samaniego, Edgar A. ^{[2
]}

Naravetla, Bharath Reddy ^{[3
]}

Zaidat, Osama O. ^{[4
]}

Hussain, Muhammad Shazam ^{[1
]}

机构：

[1] Cleveland Clin, Cleveland Clin Stroke Program, Cleveland, OH 44106 USA

[2] Stanford Univ, Stanford Stroke Ctr, Palo Alto, CA 94304 USA

[3] Univ Calif San Francisco, Neurovasc Serv, San Francisco, CA 94143 USA

[4] Med Coll Wisconsin, Neurointervent Div, Milwaukee, WI 53226 USA

来源：

NEUROLOGY | 2012年 / 79卷 / 13期

关键词：

ACUTE ISCHEMIC-STROKE; RANDOMIZED CONTROLLED-TRIAL; DIRECT THROMBIN INHIBITORS; SECONDARY PREVENTION; ASPIRIN RESISTANCE; COLLABORATIVE METAANALYSIS; ATRIAL-FIBRILLATION; FACTOR XA; CLOPIDOGREL; THERAPY;

D O I：

10.1212/WNL.0b013e3182695871

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Understanding of the pharmacology of thrombolytics, anticoagulants, and antiplatelets is critical to performing safe and effective endovascular therapy for acute ischemic therapy. This is a basic review of the clinical pharmacologic data on the anticoagulants, antiplatelets, and fibrinolytic agents most commonly used in the treatment of stroke and in the neurointerventional suite. Neurology (R) 2012;79 (Suppl 1):S68-S76

引用

页码：S68 / S76

页数：9

共 50 条

[31] Pharmacogenetics of antiplatelets and anticoagulants: a report on clopidogrel, warfarin and dabigatran
Ross, Stephanie
Pare, Guillaume
[J]. PHARMACOGENOMICS, 2013, 14 (13) : 1565 - 1572
[32] An audit of and algorithm creation for patients on anticoagulants/antiplatelets with epistaxis
Toner, F.
McKernon, D.
Scally, C.
[J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S116 - S116
[33] Antiplatelets and anticoagulants in vitreoretinal surgery, with a special emphasis on novel anticoagulants: a national survey and review
Patel, Rupa
Charles, Stephen
Jalil, Assad
[J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 255 (07) : 1275 - 1285
[34] Impact of Antiplatelets and Anticoagulants on Prognosis of Patients with Intracerebral Hemorrhage
Hokari, M.
Shimbo, D.
Asaoka, K.
Uchida, K.
Itamoto, K.
[J]. CEREBROVASCULAR DISEASES, 2016, 42 : 133 - 134
[35] Anticoagulants/antiplatelets/antiviralsMajor bleeding: 3 case reports
[J]. Reactions Weekly, 2023, 1961 (1) : 40 - 40
[36] Antiplatelets and anticoagulants in vitreoretinal surgery, with a special emphasis on novel anticoagulants: a national survey and review
Rupa Patel
Stephen Charles
Assad Jalil
[J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2017, 255 : 1275 - 1285
[37] An Update on Novel Antiplatelets in Vascular Patients
Patelis, Nikolaos
Kakavia, Kyriaki
Maltezos, Konstantinos
Damaskos, Christos
Spartalis, Eleftherios
Matheiken, Sean
Georgopoulos, Sotirios
[J]. CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (38) : 4558 - 4563
[38] Update on anticoagulants
Oger, E
Mottier, D
[J]. PRESSE MEDICALE, 2000, 29 (19): : 1079 - 1082
[39] UPDATE ON ANTICOAGULANTS
MONTALESCOT, G
[J]. ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 1991, 40 (10): : 603 - 606
[40] THROMBOCYTE AGGREGATION INHIBITORS, ANTICOAGULANTS AND THROMBOLYTICS IN HEART-DISEASE
DARIUS, H
ERBEL, R
BELZ, GG
MEYER, J
[J]. INTERNIST, 1992, 33 (10): : 670 - 683

← 1 2 3 4 5 →